China Health Group Inc. (HKG:8225)
Hong Kong
· Delayed Price · Currency is HKD 0.135
-0.002 (-1.46%)
Apr 29, 2026, 3:52 PM HKT
China Health Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 28.56 | 26.45 | 21.43 | 13.09 | 83.6 | Upgrade
|
| Revenue | 28.56 | 26.45 | 21.43 | 13.09 | 83.6 | Upgrade
|
| Revenue Growth (YoY) | 7.98% | 23.47% | 63.68% | -84.34% | 0.65% | Upgrade
|
| Cost of Revenue | 12.17 | 16.39 | 13.21 | 7.35 | 13.24 | Upgrade
|
| Gross Profit | 16.39 | 10.07 | 8.21 | 5.74 | 70.36 | Upgrade
|
| Selling, General & Admin | 5.1 | 10.08 | 7.61 | 13.97 | 21.39 | Upgrade
|
| Other Operating Expenses | - | -0.31 | -0 | -0.05 | -0 | Upgrade
|
| Operating Expenses | 31.54 | 24.57 | 65.54 | 21.75 | 28.27 | Upgrade
|
| Operating Income | -15.14 | -14.51 | -57.33 | -16.01 | 42.09 | Upgrade
|
| Interest Expense | - | - | - | -0.02 | -0.02 | Upgrade
|
| Interest & Investment Income | 0.07 | 0.06 | 0.12 | 0.2 | 0.43 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.11 | -0.03 | -1 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -14.96 | -14.47 | -58.21 | -15.83 | 42.5 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.02 | Upgrade
|
| Pretax Income | -14.96 | -14.47 | -58.21 | -15.83 | 42.52 | Upgrade
|
| Income Tax Expense | - | 0.05 | - | - | 6.2 | Upgrade
|
| Earnings From Continuing Operations | -14.96 | -14.52 | -58.21 | -15.83 | 36.33 | Upgrade
|
| Minority Interest in Earnings | - | - | 0.2 | - | - | Upgrade
|
| Net Income | -14.96 | -14.52 | -58.01 | -15.83 | 36.33 | Upgrade
|
| Net Income to Common | -14.96 | -14.52 | -58.01 | -15.83 | 36.33 | Upgrade
|
| Net Income Growth | - | - | - | - | -40.11% | Upgrade
|
| Shares Outstanding (Basic) | 995 | 995 | 995 | 995 | 995 | Upgrade
|
| Shares Outstanding (Diluted) | 995 | 995 | 995 | 995 | 995 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | -0.18% | Upgrade
|
| EPS (Basic) | -0.02 | -0.01 | -0.06 | -0.02 | 0.04 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.01 | -0.06 | -0.02 | 0.04 | Upgrade
|
| EPS Growth | - | - | - | - | -39.98% | Upgrade
|
| Free Cash Flow | - | 8.52 | -4.88 | -5.16 | -10.28 | Upgrade
|
| Free Cash Flow Per Share | - | 0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | 57.39% | 38.05% | 38.33% | 43.87% | 84.16% | Upgrade
|
| Operating Margin | -53.02% | -54.84% | -267.57% | -122.31% | 50.34% | Upgrade
|
| Profit Margin | -52.38% | -54.88% | -270.78% | -120.90% | 43.45% | Upgrade
|
| Free Cash Flow Margin | - | 32.22% | -22.79% | -39.39% | -12.29% | Upgrade
|
| EBITDA | -14.54 | -13.9 | -57.09 | -15.86 | 42.29 | Upgrade
|
| EBITDA Margin | -50.90% | -52.55% | -266.48% | -121.16% | 50.58% | Upgrade
|
| D&A For EBITDA | 0.61 | 0.61 | 0.23 | 0.15 | 0.2 | Upgrade
|
| EBIT | -15.14 | -14.51 | -57.33 | -16.01 | 42.09 | Upgrade
|
| EBIT Margin | -53.02% | -54.84% | -267.57% | -122.31% | 50.34% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 14.57% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.